summary
Introduced
07/10/2019
07/10/2019
In Committee
07/10/2019
07/10/2019
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
116th Congress
Bill Summary
A BILL To amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V, such as buprenorphine, for maintenance or detoxification treatment, and for other purposes. 1
AI Summary
This bill aims to eliminate the separate registration requirement for practitioners to dispense certain narcotic drugs, such as buprenorphine, for maintenance or detoxification treatment. It amends the Controlled Substances Act to remove the need for practitioners to obtain a separate registration to prescribe these drugs, which are classified as Schedule III, IV, or V substances. Additionally, the bill directs the Secretary of Health and Human Services to conduct a national education campaign to encourage practitioners to integrate substance use treatment into their practices and provide information on available educational resources. The bill also allows community health aides and practitioners to dispense these narcotic drugs without being registered, as long as the drugs are prescribed through telemedicine.
Committee Categories
Health and Social Services
Sponsors (6)
Maggie Hassan (D)*,
Michael Bennet (D),
Cindy Hyde-Smith (R),
Jeff Merkley (D),
Lisa Murkowski (R),
Dan Sullivan (R),
Last Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 07/10/2019)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/116th-congress/senate-bill/2074/all-info |
| BillText | https://www.congress.gov/116/bills/s2074/BILLS-116s2074is.pdf |
| Bill | https://www.congress.gov/116/bills/s2074/BILLS-116s2074is.pdf.pdf |
Loading...